Lv4
740 积分 2025-04-14 加入
Renaissance of antiviral CD8+ T cell immunity in vaccination and disease
14天前
已完结
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors – a review of patent literature from 2019–June 2023
1个月前
已完结
CDC7 kinase inhibitors: a survey of recent patent literature (2017–2022)
3个月前
已完结
The Bromodomain Inhibitor PFI-3 Sensitizes Cancer Cells to DNA Damage by Targeting SWI/SNF
3个月前
已完结
Phase Ib Basket Expansion Trial and Alternative-Schedule Dose-Escalation Study of ATR Inhibitor Elimusertib in Advanced Solid Tumors with DNA Damage Response Defects
4个月前
已完结
Development of Ligands and Degraders Targeting MAGE-A3
4个月前
已完结
Development of Next Generation Cell-Permeable Peptide Inhibitors for the Oncological Target MAGE-A4
4个月前
已完结
Epigenetic therapy in lung cancer
5个月前
已关闭
A phase 1/2 study of ubamatamab (REGN4018): low-grade serous ovarian cancer expansion cohort
6个月前
已关闭
IL-33–ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways
7个月前
已完结
皖公网安备34019202002308
